Please assess the completion status of the following clinical trial:

Trial Title: G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients who were known to have cirrhosis of liver with portal hypertension, now decompensated with ascites/ jaundice/ bleed/ HE/ HRS~Exclusion Criteria:~* Age \<12 or \> 75 years~  * Autoimmune disorders~ * HCC~ * Sepsis ( Any culture positive: blood, urine, any other obvious source of infection: UTI, SBP)~ * Multi organ failure~ * Grade 4 HE~ * HIV seropositivity / pregnancy~ * Essential Hypertension~ * Patients being taken up for transplant~ * Refusal to participate in the study

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- G-CSF+EPO (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).